The telehealth system provider is going public in an $742m upsized offering that will enable Philips, Allianz, Teva and Takeda to exit.
Amwell, a US-based telehealth technology provider backed by electronics and medical technology producer Philips, insurance group Allianz and pharmaceutical firms Teva and Takeda, will raise $742m in its initial public offering today.
The company has increased the number of shares in the offering from 35 million to 41.2 million and priced them at $18.00, above the $14 to $16 range it set last week. Internet technology provider Google is investing $100m in a separate private placement.
Formally known as American…
